Dabur India Limited Earnings Summary — Q4 FY2026

• Revenue for Q4 FY2026 grew 7.35% YoY to Rs. 3,038 Crores, showing stabilization in top-line recovery.
• Quarterly net profit rose 15.65% YoY to Rs. 362 Crores, though it fell significantly from Q3 levels due to seasonal patterns.
• Operating margins (OPM) remained flat YoY at 15%, reflecting persistent pressure on profitability compared to peak 20% quarters.
• The balance sheet remains strong with a low debt-to-equity ratio, even as borrowings increased slightly to Rs. 1,287 Crores.
• Rural consumption volatility continues to be a primary headwind for the company's volume growth trajectory.
• Dabur maintains its status as an 'Ayurvedic Compounder' with high profit stability but slow growth velocity.
• Interest expenses rose to Rs. 40 Crores for the quarter, reflecting higher debt servicing costs.
• Other Income saw a sharp spike to Rs. 175 Crores in Q4, significantly aiding the Profit Before Tax (PBT).

Management remains focused on the 'Power Brands' strategy and maintaining dividend payouts above 70%, despite sluggish rural demand.

Stable

While YoY growth improved, the stagnation in margins and continued low-single-digit volume growth in rural markets suggests no major breakout.

Dabur faces a dual challenge of USFDA regulatory issues at its Silvassa plant and increasing competition from niche and large-scale Ayurvedic players. Growth is likely to remain in the mid-to-high single digits in the near term.